Exam II- DM, Hormones, Thyroid Flashcards
(70 cards)
Raloxifene/ Evista
Class: SERM
MOA: modulates estrogen receptors, inc BD, dec cholesterol without increased risk of E2 cancers
Significantly reduces BCa incidence
PO once daily dosing
SE: hot flashes, arthralgias, myalgias, edema, pruritis, increased risk of DVT
***CI: pregnancy, lactation, Hx of DVT, PE, stroke, retinal vein thrombosis
Calcitonin/ Miacalcin
Produced by parafollicular C cells in thyroid
decreases osteoclasts can activity
Decreases risk spinal fx, possibly hip fx too
Class: synthetic hormone
MOA: increases serum Ca
Indic: osteoporosis Tx
SE: nose bleeds, sinusitis, HA, dizziness, edema, anorexia, diarrhea, rashes
IV and nasal spray routes available
Teriparatide/ Forteo
Class: synthetic PTH analog Indic: females with osteoporosis MOA: activates bone turnover with osteoblasts activation Char: SQ, once daily, up to 24 months SE: nausea, leg cramps, dizziness
Benefits continue after discontinuation
chronic high PTH–> inc risk fx; but daily low dose PTH –> dec risk fx
Denosumab/ Prolia
Monoclonal antibodies, anti-TNF agent
Indic: osteoporosis tx, bone metastasis, RA, MMyeloma, giant cell bone carcinoma
MOA: targets RANK Ligand (usu primary signal for bone remodeling)
Char: SQ q6months
SE: increased susceptibility of infx
Sitagliptin/ Januvia
Class: dipeptidyl peptidase-4 inhibitor (DDP-4)
MOA: prevents DDP-4 breakdown of GLP-1/GIP–> increased insulin, decreased glucagon postparandially
Tends to normalize insulin without risk of hypoglycemia
Approved as monotx or with Met/Sulfonly/TZDs but not with insulin
25/50/100 mg tabs available
100mg once daily
$200-400/ month
T2DM medications and their MOAs
Biguinides (metformin): inhibits liver glucose production
Sulfonylureas: increase insulin secretion
Meglitinides: increased insulin secretion
Alpha- glucoidase inhibitors: delays intestinal glucose absorption
TZDs: decreased insulin resistance
DPP-4 inhibitors: increased postparandial insulin release
Metformin/ glucophage / fortamet
Class: biguanide
MOA: decreases hepatic glucose production, increases skeletal musc insulin sensitivity
when used alone, generally won’t cause hypoglycemia
Similar effects on hba1c as sulfonlureas with modest weight loss
SE: wt loss, abd cramping, nausea (decreased in ExR form), metallic taste, increased risk of B12 deficiency (supplementation recommended), LACTIC ACIDOSIS
CI in pts with renal impairment (creative >1.4/1.5)
500/800/1000mg BID or QD if ExR; $55-100/ month
Alendronate/ Fosamax
Class: bisphosphates
MOA: inhibits osteoclasts
Indic: primary drug to treat osteoporosis (postmenopausal and post corticosteroid tx)
SE: upset stomach, esophageal irritation/erosion, esophagitis, atypical femur fractures, osteonecrosis of jaw, myalgia,
low bioavailability
**Take away from meals! Prevent esophageal Sxs by standing upright for 30-60mins after taking PO. D/c after 5yrs increases risk vertebral fx **
Glipizide/ glyburide/ glimepiride (chlorpropamide, tolbutamide 1st generations)
Class: sulfonlureas
MOA: stimulate beta cells to inc insulin production (partially blocks ATP sensitive K channels, increasing the insulin release stage)
Second generations preferred
SE: hypoglycemia, weight gain
Generally ineffective after 5-10 years of use
Avoid in pts with sulfa allergy**
Glyburide has an increased risk of hypoglycemic events
Char: one AM dose, $4-50/month
Nateglinide (Starlix)
Repaglinide (Prandin)
Class: Meglitinide (non-sulfonylurea secretagogue)
MOA: increased insulin secretion, binds ATP dependent K channels
Prandin better than Starlix, Prandin is equal to sulfonlureas in activity
SE: hypoglycemia, weight gain
Approved for use with metformin, Sulfonylurea
Rapid,y absorbed in GI
TID-QID dosing before each meal, do not take if meals are skipped
No generic available $150-300/month
Rosiglitazone (Avandia)
Pioglitazone (ACTOS)
Class: thiazolidinediones (TZDs)/ glitazones
MOA: increase insulin sensitivity in skeletal muscle, decrease liver glucose production
Dosed once daily, may take 6-14 wks to have effect. Approved as mono therapy or with Sulfonylurea/ metformin
Only ACTOS is approved with insulin
SE: inc risk CHF, MI, dec BMD, inc risk fx, weight gain
*monitor lv fxn tests at 1 month and q3months
$125-200/month
Acarbose (precose)
Miglitol (Glyset)
Class: alpha-glucosidase inhibitors
MOA: inhibits brunch border alpha glucosidase in SI –> inhibited carbohydrate hydrolysis–> delayed glucose abs
Must be taken with each meal
No hypoglycemic risk alone, but inc risk with sulfonylurea/ insulin use
TID-QID $90-125/month
SE: abd pain, diarrhea, flatulence, inc transaminases, hepatic failure (acarbose)
CI: chronic intestinal dz, IBD, colonic ulceration, intestinal obstruction
*incase of hypoglycemia, give GLUCOSE, not sucrose
Pramlintide/ Symlin
Class: synthetic amylin (usu produced with insulin in beta cells)
Indic: Type 1 and 2 diabetics who use insulin
Allows put to use less insulin
Cannot be injected in same vial/syringe as insulin
1st drug for type 1 diabetics since insulin!
Inject at meal times
SE: modest weight loss, nausea (improves with optimal dose)
Exenatide/ Byetta
Class: incretin mimetics, synthetic exedin-4 hormone
Isolated from the Gila monster
Increases insulin secretion
Does not inc risk of hypoglycemia on its own, but can if taken with sulfonylureas
Sildenafil citrate / viagra
Tadalafil/ Cialis
Vardenafil/ Levitra
Class: phosphodiesterase type 5 inhibitor
MOA: increases cyclic GMP in smooth muscle–> inc blood in c.cavernosum
Indic: ED, pulmonary hypertension
SE: cyanopsia, photophobia, HA, flushing, hypotension, glaucoma, stroke, priapism
No erection without stimulation
25/50/100mg tabs available
Take 30mins to 4hrs prior to intercourse, no more than 1 tab qd
CI: nitrites, nitrates, NO, nitroglycerin…. Liver/renal impairment, hypotension, degenerative retinal disorders
Doxazosin (Cardura)
Terazosin (Hytrin)
Tamsulosin (Flomax/Urimax)
Silodosin (Urief)
Alpha blockers
Indic: BPH
All equally effective
SE: weakness, orthostatic hypotension, nasal congestion
Finasteride/ Proscar
Class: type 2 5-a-reductive inhibitor
MOA: decs DHT conversion, anti-androgen if
Indic: BPH, male pattern baldness, prostate CA
SE: dec libido, ED, impotency, depression, breast tenderness, breast swelling
PREGNANT FEMALES SHOULD NOT HANDLE
Leuprolide/ Lupron
Anti- androgenic, anti-estrogen if
Indic: prostate ca, precocious puberty, endometriosis, uterine fibroids, some IVF protocols
GnRH synthetic analog, interrupts T and E2 production
SE: dec libido, impotence, N/V, hot flashes, night sweats, arthralgias, myalgias, osteoporosis
Clomiphene/ Clomid
Class: SERM
Indic: infertility, amenorrhea
MOA: binds estrogen receptor sites –> inc GnRH –> inc LH, FSH –> ovulation stimulation
SE: multiple gestations, vaginal dryness, anxiety, hot flashes
Usual etiology for primary vs secondary vs tertiary hypothyroidism
Primary: autoimmune thyroiditis, iodine deficiency, malnutrition, surgery/ ablation
Secondary: pituitary dysfunction
Tertiary: hypothalamic dysfunction
1 grain equivalent doses for
Armor thyroid
Synthroid
Cytomel
1g= 60mg Armour Thyroid= 100mcg of T4 (Synthroid)= 25mcg of T3 (Cytomel)
Mifepristone/ Mifeprex
synthetic steroid, abortifacient within first 2 mo of Pgx
MOA: progestin antagonist, decreases hCG
85% effective in abortion within the first trimester
often used with Cytotec (prostaglandin E1 analog)
SE: abd pain, cramping, vag bleeding for 9-16 days, N/V, diarrhea, dizziness, fatigue, fever, excessive uterine bleeding
CI: IUD, ectopic pregnancy, Prednisone Tx, hemorrhagic d/o, anticoagulation Tx
Morning after pill
1 dose 1.5mg Levonorgestrel (progestin)
or 2 doses 750microgm q12hrs
Prevents implantation, can obtain same effect by taking multiple OCPs
OR
Ulipristal acetate (Ella)
Class: SPRM
given within 5 days of unprotected sex, inhibits ovulation
Skyla
IUD with 13.5mg Levonorgestrel at implantation
14 mcg/day released
FDA approves 3yrs continued use